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Upconversion nanoparticles (UCNPs)
with sodium yttrium fluoride, NaYF4
(host lattice) doped with Yb3+ (sensi-
tizer) and Er3+ (activator) were
synthesized via hydrothermal route
incorporating polyethyleneimine (PEI)
for their long-term stability in water.
The cationic PEI-modified UCNPs
with diameter 20  4 nm showed a
zeta potential value of +36.5 mV and
showed an intense, visible red lumi-
nescence and low-intensity green
emission with 976 nm laser excitation.
The particles proven to be nontoxic to
endothelial cells, with a 3-(4,5-dimethylthiazol-2yl)-2,5-diphenyltetrazolium bro-
mide (MTT) assay, showing 90% to 100% cell viability, across a wide range of
UCNP concentrations (0.3 ng/mL-0.3 mg/mL) were used in multiphoton imaging.
Multiphoton cellular imaging and emission spectroscopy data reported here prove
that the UCNPs dispersed in cell culture media are predominantly concentrated in
the cytoplasm than the cell nucleus. The energy transfer from PEI-coated UCNPs
to surrounding media for red luminescence in the biological system is also
highlighted with spectroscopic measurements. Results of this study propose that
UCNPs can, therefore, be used for cytoplasm selective imaging together with mul-
tiphoton dyes (eg, 40,6-diamidino-2-phenylindole (DAPI)) that are selective to cell
nucleus.
KEYWORDS
cellular imaging, luminescence upconversion, nanomaterials, toxicity,
upconversion nanoparticles
1 | INTRODUCTION
Upconversion is a nonlinear optical process in which multi-
ple photons in the near infrared (NIR) wavelength are
absorbed by certain rare earth (RE) doped materials, which
then emit photons at visible wavelengths via luminescence
[1]. RE-doped upconversion nanoparticles (UCNPs) have
emerged as a new class of inorganic optical probes that
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might overcome some of the shortcomings of fluorescent
proteins and quantum dots [2]. UCNPs have advantageous
properties associated with their infrared excitation, including
low toxicity, no visible autofluorescence or photobleaching
and excellent photostability [3]. The infrared excitation of
UCNPs also enables imaging through up to 2 cm of tissue
due to lower scattering and absorption by tissue at these
wavelengths [4]. Furthermore, UCNP emission can be tuned
by varying elemental composition to enable multiplexed
measurement [2, 5–17].
To meet the needs in advanced biomedical and environ-
mental applications, several experimental methods have
been developed in order to synthesize UCNPs [18–33]. The
hydrothermal method and associated modifications provide
several ways to synthesize UCNPs [5–7, 12, 13, 34, 35].
Recently, imaging using luminescent UCNPs as a fluoro-
phore alternative has been reported as a unique approach for
visualizing morphological details in tissue at subcellular res-
olution with no visible autofluorescence and has become a
powerful noninvasive tool for bioimaging [3, 5, 12, 34].
Because of the inherent high photostability and nonblinking
emission behavior, UCNPs have been shown to enable reli-
able molecular imaging with long time tracking capability
[12, 35]. Zijlmans et al [36] first exploited the upconversion
properties of lanthanide-doped particles for high-
performance bioimaging applications. It has been shown by
Yu et al [37] that upconversion-based visualization has neg-
ligible fading effect over time. Yu et al [37], Chatterjee
et al [38], and Xiong et al [39] have established UCNPs as
luminescent labels for bioimaging in living cells, and Prasad
et al [40] reported in vivo imaging with Tm3+ as well as
Yb3+ doped nanophosphors. High-contrast cellular imaging
has been reported using NIR to visible and NIR to NIR
UCNPs [38, 41, 42]. Initial attempts have been made in using
UCNPs in the imaging of certain cancer cells [38, 41–43].
In the present study, water-dispersible polyethyleneimine
(PEI)-modified NaYF4/Yb
3+/Er3+ UCNPs have been synthe-
sized. In addition to adopting hydrothermal method, the
purification process that we followed is important to achieve
highly homogeneous aqueous suspension of nanoparticles
with less aggregates reported here. The purification involved
ultrasonication and redispersion in deionized water followed
by filtering through a PD10 column. Although addition of
just PEI and use of hydrothermal method have been adopted
before, in the present study, we have optimized the proces-
sing time, purification and dispersion procedures to get a sta-
ble suspension, which are very important to get a stable
colloidal suspension for further applications. These PEI-
modified UCNPs, we prepared in this study, were assessed
with respect to size distribution, zeta potential, crystallinity
and luminescence. PEI-modified UCNPs were used for mul-
tiphoton imaging within homogenized liver tissue and endo-
thelial cells. The possible mechanism of luminescent
resonance energy transfer (LRET) which is the reason for
variation in fluorescence intensities in the visible spectrum
in the biological system is discussed in the paper. We also
demonstrated that the UCNPs synthesized in this study cause
little tissue and cell toxicity and are mainly taken up into the
cell cytoplasm. This is promising for site-selective imaging
applications of PEI-modified UCNPs.
2 | EXPERIMENTAL SECTION
2.1 | Materials
Analytical grade branched PEI (Sigma Aldrich, UK, Molec-
ular weight 25 KDa) and all other reagents including
Y(NO)3.6H2O, Yb(NO)3.5H2O, Er (NO)3.5H2O, NH4F,
NaCl, ethylene glycol (EG) and acetone were purchased
from Sigma Aldrich, UK. Ultrapure (R = 18 MΩ) water
was used for final washing of the precipitate and dispersion
of the nanoparticles.
2.2 | Nanoparticle synthesis
The experimental procedure used for UCNP synthesis was a
modification of the synthesis method reported by Zhang
et al [44]. NaCl (10 mmol), Y(NO)3.6H2O (3.12 mmol), Yb
(NO)3.5H2O (0.8 mmol), Er (NO)3.5H2O (0.08 mmol) and
1.6 g of PEI were dissolved in 60 mL EG by stirring for
2 hour to form an RE solution. About 16 mmol NH4F was
dissolved in 40 mL of EG was prepared separately and was
added to the mixed RE solution containing NaCl solution
and PEI. The resultant solution was stirred for a further
15 minutes. The whole mixture was then transferred to a
120 mL Teflon-lined Parr pressure vessel and hydrother-
mally heated at 200C for 2 h. The resultant solution was
then allowed to cool down to room temperature, and the con-
tents including a very fine precipitate consisting of UCNPs
were transferred into a beaker before washing 3 to 4 times
with acetone, and then 4 to 5 times with ultrapure water by
repeated ultracentrifugation at 80 000 times gravity for
30 minutes using a Beckman Avanti J20XP high-speed cen-
trifuge (Fullerton, California, USA). The nanoparticle pellet
obtained was redispersed by sonication using an ultrasonic
probe for a maximum of 30 seconds (Bandelin GM2070 with
100% power; cycle 0.7 seconds). The purified nanoparticles
were resuspended in 4 to 5 mL of water and passed through a
desalting column (PD10; GE Healthcare Life Sciences,
Pharmacia Biotech Inc., UK) to separate the aggregated and
finer “UCNPs.” The following sections exclusively discuss the
NaYF4/Yb
3+/Er3+ UCNPs modified with PEI thus obtained.
2.3 | Transmission electron microscopy and dynamic
light scattering (DLS)
High-resolution transmission electron microscopy of the
sample was performed using a TecnaiG2 high-resolution
field-emission transmission electron microscope (HRFE-
TEM). The sample for the TEM was prepared by placing a
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drop of UCNPs suspended in water onto the surface of a
holey carbon-coated Cu grid and letting the water evaporate
prior to imaging. The size distribution of nanoparticles was
estimated from TEM images by using a custom MATLAB
algorithm (MATLAB 2016a), based upon a circular Hough
transforms to detect the pseudo-spherical UCNPs [45]. The
diameter of the nanoparticle in pixels was subsequently con-
verted to nanometer (nm) by known scale calibration of the
HRFE-TEM. Selected area electron diffraction (SAED) was
used to verify the lattice planes by comparing with known
reference patterns. Energy-dispersive X-ray (EDX) analysis
of the sample was also performed during HRFE-TEM to
confirm the elemental composition.
DLS was used to ascertain the hydrodynamic diameter
and zeta potential of the UCNPs when dispersed in water.
Malvern Zetasizer Nano Zs system (Malvern, UK) was used
for the DLS measurement.
2.4 | X-ray diffraction measurement
X-ray diffraction (XRD) measurements of the sample pow-
der obtained by drying the sample at 100C were made with
an X-ray diffractometer (Bruker D4) using Cu Kα radiation
(λ = 1.5418 A) in the 2θ range 10 to 80 in 0.0247
increments.
2.5 | Luminescence emission spectroscopy
In order to measure the luminescence, the sample solution was
loaded into 2.0 mL quartz Suprasil cuvettes (Hellma Analytics,
UK) placed within a cuvette holder (qpod 2e, Ocean Optics
Inc., Liberty Lake, Washington, USA) at room temperature.
The sample was illuminated with a 976 nm NIR laser
(BL976-PAG900; Thorlabs, New Jersey, USA), operating at a
power corresponding to 1000 mA current. UCNP emission was
recorded using a high-performance spectrometer (QE-PRO,
Ocean Optics, Florida, USA) with 1-second integration time
and no data averaging.
2.6 | In vitro endothelial cell culture
Human umbilical vein endothelial cells (HUVECs; Promo-
Cell, Germany) were used for the in vitro cell study. Passage
of cells was carried out by standard trypsinization (Sigma
Aldrich, UK). After centrifugation, the pellet was resus-
pended and cells counted using a hemocytometer. HUVECs
(1 × 104) were grown overnight in a 96-well plate. Growth
media were prepared using a PromoCell endothelial cell
growth medium (PromoCell GmbH, Heidelberg, Germany)
supplemented with PromoCell endothelial cell supplements
(PromoCell GmbH, Heidelberg) and 10% (v/v) Gibco fetal
calf serum and used to feed the growing cells every 2 days
until the cells reached ~90% confluency. Media were filtered
using Millipore Express polyethersulfone (PES) membranes
(pore size 0.22 μm, diameter 33 mm, sterile; γ-irradiated,
UK) and Terumo syringes (Terumo, UK).
2.7 | In vitro cytotoxicity evaluation
The in vitro cell viability of UCNPs within endothelial cells
was assessed using the 3-(4,5-dimethylthiazol-2yl)-
2,5-diphenyltetrazolium bromide (MTT) (Sigma Aldrich, UK)
assay. Briefly, 104 HUVECs were grown overnight in a
96-well plate. Growth medium was prepared using a Promo-
Cell endothelial cell growth medium supplemented with Pro-
moCell endothelial cell supplements and 10% (v/v) fetal calf
serum. Increasing doses of nanoparticles from 0.3 ng/mL to
300 μg/mL in growth media were added and incubated for a
period of 24 hours. The MTT assay was carried out after
24 hours by adding 50 μL of 5 μg/mL MTT to each well.
After the addition of MTT, the plate was incubated for a
period of 3 hours, until the purple product appeared. Then, the
purple crystals were dissolved using 300 μL/well of isopropa-
nol, and the plate was read at 576 nm. Cell morphology was
observed under light microscope (Olympus BX41, Japan)
using Cell F imaging software for Life science microscopy in
order to examine any change after addition of nanoparticles.
2.8 | In vivo toxicity testing for liver tissue
All experiments were performed on 10-week-old, 25 g to 30 g
male C57BL/6J mice (Harlan Olac, Bicester, UK), under
appropriate United Kingdom Home Office personal and pro-
ject licenses, adhering to the regulations as specified in the
Animals (Scientific Procedures) Act (1986), and according to
institutional ethical guidelines. The mice were anesthetized
with isoflurane (1%-1.5% in oxygen). The test mice were
injected with 100 μL of 0.2 mg/mL of UCNPs in 0.1 M phos-
phate buffer saline (PBS, pH 7.6) intraperitoneally. Control
mice were injected with 100 μL of PBS (pH 7.6). Following
48 hours, both experimental and control mice were perfused
transcardially with PBS followed by 4% paraformaldehyde in
0.1 M phosphate buffer (pH 7.4). Liver tissue was harvested
and stored in PBS until further processing. For in vivo toxicity
assessment, a part of the liver was fixed in paraformaldehyde
and embedded in paraffin using a MEDITE Paraffin Embed-
ding System TES 99, GmbH, Germany. The embedded tis-
sues were cut into thin sections using a Leica RM2235 (Leica
Biosystems, GmbH, Germany) rotary microtomes and conse-
quently processed and stained with standard hematoxylin and
eosin staining. The histological sections were observed under
an Olympus BX41 bright field microscope, and the digital
images were monitored using Image Pro Plus 7 software
(Media Cybernetics, UK) for tissue morphology to establish
the nontoxicity of the nanoparticles toward tissues.
2.9 | Multiphoton imaging of ex vivo liver tissue
Mice were killed by decapitation under anesthesia (isoflur-
ane, 1%-1.5% in oxygen), liver removed and kept in PBS.
Part of the liver tissue was cut and homogenized with a blunt
needle. About 100 μL of the UCNPs (diluted 1 μL in 10 000
μL PBS) were added to the tissue and mixed the particles with
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the tissue by further homogenization and vortexing. The
homogenized tissue with embedded UCNPs was mounted on
a slide and air-dried in a refrigerator. The samples were cover-
slipped using the mounting medium containing 40,6-diami-
dino-2-phenylindole (DAPI) (Vectashield antifade mounting
medium with DAPI, Vector Laboratories, UK) and viewed
under multiphoton microscope.
2.10 | Multiphoton imaging of endothelial cells
HUVECs were grown on small circular coverslips on an
8-well plate in the exactly the same way as mentioned in the
in vitro toxicity evaluation measurements. After the cells
became confluent, 50 μL of 0.3 ng/mL of nanoparticle solu-
tion was added and incubated for 24 hours. A coverslip with
cells without nanoparticle was used as the control. After
incubation, the cells were fixed using 70% methanol. The
coverslip with samples were mounted on a glass slide with
the mounting medium containing DAPI (Vectashield anti-
fade mounting medium with DAPI; Vector Laboratories,
UK) and observed under the multiphoton microscope.
Images were acquired using a multiphoton microscope
(Upright Zeiss 710; Chameleon, Coherent, Glasgow, UK)
with tunable laser excitation (690-1064 nm); 980 nm
was selected as it corresponds to peak excitation of
NaYF4/Yb
3+/Er3+ UCNPs. An external nondescanned
detector was used to acquire Multiphoton images (Carl Zeiss,
Jena, Germany). Emission spectroscopy analysis of cells was
enabled by a spectral detector with photonmultiplier tube
(Carl Zeiss, Germany). All measurements were acquired at
100% excitation power, corresponding to 180 mW.
3 | RESULTS AND DISCUSSIONS
3.1 | Transmission electron microscopy of UCNPs
HRFE-TEM images of the UCNPs showed a homogeneous
distribution with an approximate spherical morphology, with
an average particle diameter of 20  4 nm (mean  SD)
(Figure 1A-C). The 2D crystal lattice fringes are visible in
Figure 1D; and the distance between the crystal planes are
determined to be 3 and 2.6 Å, corresponding to the (111)
plane and (200) plane, respectively [46]. The SAED pattern
(Figure 1E) demonstrates the highly ordered crystal structure
of the UCNPs with the (111), (200) and (220) crystal planes
clearly present. From the distance between the crystal planes,
(A) (B) (C)
(D) (E)
5 nm 5 nm
-1
200 nm 200 nm
(111)
(200)
(220)
(311)
FIGURE 1 (A) TEM image of the NaYF4/Yb
3+/Er3+ UCNPs as synthesized. (B) Detection of UCNPs for size analysis; the blue circles show nanoparticles
selected for analysis. (C) Resultant size distribution, showing a normal distribution with an average UCNP diameter of 20  4 nm (mean  SD). (D) HRFE-
TEM image of UCNPs. (E) Selected area diffraction pattern demonstrating peaks from UCNP crystal planes
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it can be inferred that UCNPs prepared in this research have
α-NaYF4 cubic crystal phase [20]. The EDX analysis spec-
trum reported in Supporting Information Figure S1 indicates
the molar ratio of the elements Na/Y/Yb/Er/F as
1/0.778/0.210/0.027/4.04, respectively. The concentration of
nitrogen at 0.87 atom percentage indicates the presence of
PEI on the surface of the particles.
3.2 | XRD analysis of UCNPs
The XRD measurements (Figure 2) also confirmed that the
crystals are cubic (α-phase) by comparison with the standard
test card (JCPDS Card No.77-2042) [20]. The hkl matches
with TEM data for the first three planes. From the 2θ peak
positions, the cubic lattice parameter, a was calculated to be
5.47  0.02 Å (mean  SD calculated from six individual
peaks).
3.3 | DLS measurements (particle size in suspension
and zeta potential)
Figure 3A and B shows the distribution of particles sizes of
the UCNPs in solution and the zeta potential measurement
respectively, measured using DLS. The particle size distribu-
tion of the UCNPs by DLS indicated that the maximum par-
ticles with mean particle diameter of around 100 nm
(Figure 3A). Owing to the outer layer of PEI coating on the
UCNPs, an increase in hydrodynamic diameter is expected
compared with the UCNP size calculated by TEM [44].
Consistent with surface modification by PEI, the PEI-UCNP
constructs showed excellent long-term stability in water
without any noticeable agglomeration. The long-term water
stability makes these PEI-UCNPs suitable for bioimaging
applications. The maximum apparent zeta potential value of
+36.5 mV was found to be highly consistent with the isola-
tion of PEI-coated UCNPs. The value suggests that PEI-
UCNPs have cationic surfaces; this can be attributed to the
−NH2 group of the PEI being attached to the particle surface
as a hydrophilic head [44]. The positive zeta potential is
advantageous for two reasons: (a) improved stability in
water and (b) better cell membrane permeability than nega-
tively charged particles [47]. Thus high zeta potential value
is a highly favorable property for tissue and cellular
imaging.
3.4 | Luminescence emission of UCNPs
Figure 4A shows the homogeneous suspension when not irra-
diated with 976 nm laser; the white opaque appearance is due
to nonabsorptive light scattering by the PEI-UCNPs. Under
976 nm illumination, UCNPs show apparent orange/red emis-
sion visible to the eye (Figure 4B). The UCNP luminescence
emission spectrum of the suspension with 976 nm excitation
is shown in Figure 4C. The sharp doublet peak in the red
wavelength range (635-694 nm) is due to the 4F9/2 ! 4I15/2
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FIGURE 3 (A) DLS particle size distribution of UCNPs showing maximum particles with mean size corresponding to a hydrophobic diameter of around
100 nm. (B) Zeta potential measurement of the UCNPs showing high surface charge
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FIGURE 2 XRD pattern of UCNPs. Comparison of the distinct diffraction
peaks with known reference shows that the UCNPs are of cubic crystal
structure
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transitions, while the weak emission band at 540 to 560 nm
results from the (4S3/2,
2H11/2) ! 4I15/2 transitions. The com-
bination of both red and green under 976 nm NIR irradiation
results in the deep orange/red emission in the visible light
region as shown in Figure 4B.
3.5 | In vitro cytotoxicity assessment in endothelial cell
and in vivo liver toxicity assessment
Cytotoxicity is a concern whenever nanoparticles are applied
to the imaging of cells or tissues. An MTT assay was used to
assess the cytotoxicity of the UCNPs on human endothelial
cells. Incubating the cells with UCNPs for 24 hours resulted
in average cell viability of 90% to 100% (Figure 5), indicat-
ing that UCNPs are nontoxic to endothelial cells. Further-
more, no change in cell number or morphology was
apparent with the maximum concentration of UCNPs
(300 μg/mL), indicating good cell viability (Supporting
Information Figure S2).
Recent work by Zou et al [48] indicates that when
UCNPs are introduced to mice, the UCNPs accumulated in
the liver after 24 hours. In this research, in vivo toxicity
assessment of the UCNPs was carried out in mice. The
microscopy images of liver tissue from mice injected with
UCNPs and stained with hematoxylin and eosin shown in
Figure 6 suggest no apparent tissue damage or lesions in the
UCNPs incorporated tissues compared with the control.
There was no visible difference in morphology between the
control (Figure 6A) and the tissues with the UCNPs
(Figure 6B), indicating no apparent toxicity effect of the
UCNPs on liver tissues after 48 hours incubation.
3.6 | Multiphoton microscopy of UCNPs within
homogenized liver tissue and endothelial cells
Figure 7A shows the multiphoton image of the liver tissue
homogenized with the UCNPs, excited at 980 nm. The char-
acteristic green and red emission luminescence spectra of
UCNPs were observed in the homogenized liver tissue (see
Figure 7B). The spectra are distinct from the typical liver auto-
fluorescence, which under normal ultraviolet or visible excita-
tion is typically a continuous peak ranging from 400 to
650 nm [49]. Note, the sharp peaks of UCNPs are not clearly
resolved in Figure 7B due to the low spectral sampling resolu-
tion of the multiphoton microscope (approximately 10 nm).
The spectral emission data of UCNPs in tissue shows a
pseudo-uniform distribution of particles in the homogenized
tissue. The red emission peak was greatly reduced compared
with the UCNPs in as prepared solution (see Figure 4C) sug-
gesting that red emission quenching in Figure 7B is due to a
localized interaction between the UCNPs and molecular
FIGURE 4 (A) Photograph of the stable UCNP dispersion without
excitation in a glass cuvette. (B) UCNP luminescence under 976 nm laser
excitation showing orange/red luminescence to the eyes. (C) Luminescence
emission spectrum of UCNPs recorded by a spectrometer showing peaks in
the green (~540 nm) and red (~660 nm) regions, with the red peak showing
considerably greater intensity
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FIGURE 5 MTT cell viability assay of human endothelial demonstrating
the UCNPs are not cytotoxic to endothelial cells. (a) Control (b-h) various
concentrations of UCNPs introduced to the sample; 0.3 ng/mL, 3 ng/mL,
30 ng/mL, 300 ng/mL, 3 μg/mL, 30 μg/mL and 300 μg/mL, respectively
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constituents of liver tissues. The peak intensity ratio of red
to green is 24.3 for UCNPs in solution while that in liver tis-
sues is 1.03. The UCNP emission ratio between red and
green is also nonuniform across the homogenized tissue
sample though there is a drop in red intensity in comparison
with green everywhere. The reason for this is due to local-
ized interactions between the UCNPs and the variations in
the molecular sites in the homogenized tissue that is attached
to the UCNPs, resulting in energy loss from the UCNPs via
LRET identical to that observed in RE complexes [50].
These data support that UCNPs are suitable for tissue imag-
ing without autofluorescence.
Studies have also been conducted to see the interaction
and uptake of UCNPs by endothelial cells. Figure 8A shows
the multiphoton image of the endothelial cells with mount-
ing medium containing DAPI and UCNPs when excited at
760 nm. The image clearly shows only the DAPI-stained
cell nucleus at this excitation wavelength. Figure 8B showed
the overlay images obtained at 760 and 980 nm, respec-
tively. It can be clearly seen that the particles are predomi-
nantly attached to the cells around the nucleus, and the cell
morphology is not affected. This is consistent with the previ-
ous observation [51].
In order to confirm the origin of the intense green emis-
sion, the spectra were recorded from various locations within
the cell media and reported in Figure 8C. The spectrum
recorded in the cytoplasm clearly shows characteristic dual-
emission peak of UCNPs, whereas the nucleus shows no
emission, indicating UCNPs are only absorbed into the cyto-
plasm and not into the nucleus. Figure 8B,C shows that
UCNPs are localized in the cytoplasm but not in the nucleus.
This clearly demonstrates the importance of UCNPs in the
selective multiphoton imaging of cellular cytoplasm. The
wavelengths of emission from the cytoplasm (Figure 8C)
also show relatively higher emission intensity in the green
FIGURE 7 (A) Multiphoton image of the homogenized mouse liver tissue with UCNPs after 48-hour incubation, excited at 980 nm. The reason for spatial
distribution of red and green emission is currently unclear. (B) Representative λ-scan emission spectrum of the corresponding image at 980 nm excitation
clearly showing the characteristic green and red luminescence peaks of UCNPs
(A)
(B)
200 µm 
200 µm 
FIGURE 6 Hematoxylin and eosin stained liver tissue with and without
injection of UCNPs. No apparent morphological difference between the
control sample (A) and the tissue sample with UCNPs (48 hours
postinjection) (B) is evident from the images
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region than the red region. The ratio of red to green (R/G)
peak intensity in this spectrum is 0.18, which is significantly
lower than that of UCNPs in solvent reported in
Figure 4C. The quenching of red emission could be attrib-
uted to the LRET from the UCNPs to the cellular proteins,
located within 20 nm of UCNPs similar to that described
above for UCNPs in liver tissues. However, in both cases, a
detailed understanding of the LRET requires knowledge of
the molecules in the biological media that preferentially
attaches to UCNPs and time-resolved spectroscopic studies.
Figure 8 also demonstrates that DAPI can be used in con-
junction with UCNPs for dual wavelength excitation for
selective imaging of nucleus and cytoplasm, respectively.
Results reported here are promising for using the PEI-coated
UCNPs safely in multiphoton bioimaging applications with
multiple wavelength imaging modality.
4 | CONCLUSIONS
PEI-modified NaYF4/Yb
3+/Er3+ UCNPs were synthesized
by a novel hydrothermal method. HRFE-TEM showed par-
ticles with a mean diameter of 20  4 nm and an overall
diameter range between 10 and 35 nm. Measurements with
DLS indicated a much wider diameter distribution when in
solution, with a mean nanoparticle diameter of ~100 nm
due to the hydrated PEI outer layer. The UCNP zeta poten-
tial value of +36.5 mV indicates the cationic surface of the
particles and PEI modification increased the water stability
of the nanoparticles; an important parameter for cellular
uptake in bioimaging applications. The nontoxicity of the
particles toward liver tissue and endothelial cells was con-
firmed by hematoxylin and eosin staining and MTT assays,
respectively. Imaging of UCNPs in the presence of homog-
enized liver tissue exhibited the characteristic luminescence
spectra of UCNPs, indicating that UCNPs can be used for
tissue imaging without background tissue autofluorescence.
Multiphoton imaging and emission spectroscopy of endo-
thelial cell utilizing UCNPs indicated that UCNPs are
absorbed into the cytoplasm, but not to the nucleus. This
indicates that UCNPs are suitable for cell structure applica-
tions and that our PEI-modified UCNPs were uptaken into
the cytoplasm specifically. This initial study demonstrates
that in the future, UCNPs could be applied to bioimaging
of cell structures and tissue imaging. LRET, which is the
main cause of drop in luminescence intensity of red relative
to green for UCNPs in biological media, is observed in this
research. With appropriate surface modification and suit-
able bioconjugation procedures, UCNPs could be utilized
for targeted imaging and as biosensors for sensing of bio-
molecules and proteins.
ACKNOWLEDGMENTS
The corresponding author P.P.N., a Marie Skłodowska-
Curie Experienced Researcher, has received funding from
the European Commission Horizon 2020 Framework
Programme—H2020 Marie Skłodowska-Curie Actions
under the Grant Agreement No. 707297. P.P.N. would like
to thank Hema Viswambharan for her guidance on
HUVECs culture and stimulation. P.P.N. acknowledges
Nadira Yuldasheva and Nicole Conway for their technical
support in light microscopic tissue preparation and staining.
P.P.N. acknowledges the British Heart Foundation,
Wellcome Trust and University of Leeds, UK for
having the Multiphoton Fluorescence Laser Imaging
Facility in Leeds Institute for Cardiovascular and Metabolic
Medicine (LICAMM), used for this research work.
P.P.N. acknowledges David S. Myers for helping with the
multiphoton imaging tasks. L.E.M. was funded by a grant
from the Biotechnology and Biological Sciences Research
Council Tools and Resources Development Fund. A.V. was
FIGURE 8 Multiphoton images of DAPI-stained endothelial cells with low concentration of nanoparticles (0.3 ng/mL) added and subsequently incubated for
24 hours. (A) 760 nm excitation, highlighting the DAPI-stained cell nucleus only. (B) 980 nm excitation image of excited UCNPs overlaid upon (A) showing
apparent UCNP emission from cytoplasm. (C) λ-curve showing the wavelength of emission from the cytoplasm, nucleus and control cells at 980 nm
8 of 9 NAMPI ET AL.
funded by the Natural Environment Research Council,
UK. N.S.S. is an Engineering and Physical Sciences
Research Council (EPSRC) Established Career Fellow.
AUTHOR BIOGRAPHIES
Please see Supporting Information online.
ORCID
Padmaja P. Nampi https://orcid.org/0000-0001-8702-0060
REFERENCES
[1] F. Auzel, Chem. Rev. 2004, 104, 139.
[2] F. Wang, D. Banerjee, Y. S. Liu, X. Y. Chen, X. G. Liu, Analyst 2010,
135, 1839.
[3] J. J. Zhou, S. Q. Xu, J. J. Zhang, J. R. Qiu, Nanoscale 2015, 7, 15026.
[4] Q. Liu, Y. Sun, T. Yang, W. Feng, C. Li, F. Li, J. Am. Ceram. Soc. 2011,
133, 17122.
[5] M. G. Bejar, L. F. Sariano, J. P. Perieto, Front. Bioeng. Biotechnol. 2016,
4, 1.
[6] D. K. Chatterjee, M. K. Gnanasammandhan, Y. Zhang, Small 2010, 6,
2781.
[7] M. Haase, H. Schafer, Angew. Chem. Int. Ed. 2011, 50, 5808.
[8] X. M. Li, F. Zhang, D. Y. Zhao, Nano Today 2013, 8, 643.
[9] B. Zhou, B. Y. Shi, D. Y. Jin, X. G. Liu, Nat. Nanotechnol. 2015, 10, 924.
[10] X. G. Liu, C. H. Yan, J. A. Capobianco, Chem. Soc. Rev. 2015, 44, 1299.
[11] H. Dong, L. D. Sun, C. H. Yan, Nanoscale 2013, 5, 5703.
[12] G. Y. Chen, H. L. Qiu, P. N. Prasad, X. Y. Chen, Chem. Rev. 2014, 114,
5161.
[13] Z. J. Li, Y. W. Zhang, H. E. La, R. Zhu, G. El-Banna, Y. Z. Wei, G. Han,
Nanomaterials 2015, 5, 2148.
[14] C. Bouzigues, T. Gacoin, A. Alexandrou, ACS Nano 2011, 5, 8488.
[15] M. V. DaCosta, S. Doughan, Y. Han, U. J. Krull, Anal. Chim. Acta 2014,
832, 1.
[16] L. Y. Ang, M. E. Lim, L. C. Ong, Y. Zhang, Nanomedicine 2011, 6, 1273.
[17] D. Yang, P. Ma, Z. Hou, Z. Cheng, C. Li, J. Lin, Chem. Soc. Rev. 2015, 44,
1416.
[18] G. S. Yi, H. C. Lu, S. Y. Zhao, G. Yue, W. J. Yang, D. P. Chen,
L. H. Guo, Nano Lett. 2004, 4, 2191.
[19] Y. Wei, F. Q. Lu, X. R. Zhang, D. P. Chen, Chem. Mater. 2006, 18, 5733.
[20] H. X. Mai, Y. W. Zhang, R. Si, Z. G. Yan, L. D. Sun, L. P. You,
C. H. Yan, J. Am. Chem. Soc. 2006, 128, 6426.
[21] J. C. Boyer, F. Vetrone, L. A. Cuccia, J. A. Capobianco, J. Am. Chem. Soc.
2006, 128, 7444.
[22] G. S. Yi, G. M. Chow, Adv. Funct. Mater. 2006, 16, 2324.
[23] S. Mishra, S. Daniele, G. Ledoux, E. Jeanneau, M. F. Joubert, Chem. Com-
mun. 2010, 46, 3756.
[24] W. B. Niu, S. L. Wu, S. F. Zhang, L. Li, Chem. Commun. 2010, 46, 3908.
[25] H. Schafer, P. Ptacek, H. Eickmeier, M. Haase, Adv. Funct. Mater. 2009,
19, 3091.
[26] Z. Q. Li, Y. Zhang, Nanotechnology 2008, 19, 345606.
[27] X. M. Liu, J. W. Zhao, Y. J. Sun, K. Song, Y. Yu, C. A. Du, X. G. Kong,
H. Zhang, Chem. Commun. 2009, 43, 6628.
[28] Y. A. Yang, O. Chen, A. Angerhofer, Y. C. Cao, J. Am. Chem. Soc. 2006,
128, 12428.
[29] S. H. Tang, J. N. Wang, C. X. Yang, L. X. Dong, D. L. Kong, X. P. Yan,
Nanoscale 2014, 6, 8037.
[30] S. F. Lim, R. Riehn, C. K. Tung, W. S. Ryu, R. Zhuo, J. Dalland,
R. H. Austin, Nanotechnology 2009, 20, 405701.
[31] M. Pires, O. A. Serra, M. R. Davolos, JOL 2005, 113, 174.
[32] X. Qin, T. Yokomori, Y. G. Ju, Appl. Phys. Lett. 2007, 90, 073104.
[33] Y. L. Hu, B. Y. Wu, Q. Jin, X. Y. Wang, Y. Li, Y. X. Sun, J. Z. Huo,
H. J. Zhao, Talanta 2016, 152, 504.
[34] M. Lin, Y. Zhao, S. Q. Wang, M. Liu, Z. F. Duan, Y. M. Chen, F. Li,
F. Xu, Biotechnol. Adv. 2012, 30, 1551.
[35] D. Ostrowski, E. M. Chan, D. J. Gargas, E. M. Katz, G. Han, P. J. Schuck,
D. J. Milliron, B. E. Cohen, ACS Nano 2012, 6, 2686.
[36] H. J. Zijlmans, J. Bonnet, J. Burton, K. Kardos, T. Vail, R. S. Niedbala,
H. J. Tanke, Anal. Biochem. 1999, 267, 30.
[37] M. X. Yu, F. Y. Li, Z. G. Chen, H. Hu, C. Zhan, H. Yang, C. H. Huang,
Anal. Chem. 2009, 81, 930.
[38] D. K. Chatterjee, A. J. Rufalhah, Y. Zhang, Biomaterials 2008, 29, 937.
[39] L. Q. Xiong, Z. G. Chen, M. X. Yu, F. Y. Li, C. Liu, C. H. Huang, Bioma-
terials 2009, 30, 5592.
[40] M. Nyk, R. Kumar, T. Y. Ohulchanskyy, E. J. Bergey, P. N. Prasad, Nano
Lett. 2008, 8, 3834.
[41] F. Vetrone, R. Naccache, A. J. de la Fuente, F. Sanz-Rodriguez,
A. Blazquez-Castro, E. M. Rodriguez, D. Jaque, J. G. Sole,
J. A. Capobianco, Nanoscale 2010, 2, 495.
[42] B. Sikora, K. Fronc, I. Kaminska, K. Koper, S. Szewczyk, B. Paterczyk,
T. Wojciechowski, K. Sobczak, R. Minikayev, W. Paszkowicz, P. Stepien,
D. Elbaum, Nanotechnology 2013, 24, 235702.
[43] Y. Yang, Y. Han, C. Yue, Nano. Biomed. Eng. 2016, 8, 161.
[44] S. Zhang, J. Wang, W. Xu, B. T. Chen, W. Yu, L. Xu, H. W. Song, JOL
2014, 147, 278.
[45] L. E. Mackenzie, J. A. Goode, A. Vakurov, P. P. Nampi, S. Saha, G. Jose,
P. A. Millner, Sci. Rep. 2018, 8, 1106. https://doi.org/10.1038/
s41598-018-19415-w.
[46] J. F. Jin, Y. J. Gu, C. W. Y. Man, J. P. Cheng, Z. H. Xu, Y. Zhang,
H. S. Wang, V. H. Y. Lee, S. H. Cheng, W. T. Wong, ACS Nano 2011, 5,
7838.
[47] O. S. Wolfbeis, Chem. Soc. Rev. 2015, 44, 4743.
[48] R. Zou, J. Huang, J. Shi, L. Huang, X. Zhang, K. Wong, H. Zhang, D. Jin,
J. Wang, Q. Su, Nano. Res. 2017, 10, 2070.
[49] C. Croce, A. Ferrigno, G. Santin, V. M. Piccolini, G. Bottiroli, M. Vairetti,
Laser Surg. Med. 2014, 46, 412.
[50] H. E. Rajapaksea, N. Gahlauta, S. Mohandessia, D. Yub, J. R. Turnerb,
L. W. Millera, PNAS 2010, 107, 13582.
[51] D. H. M. Dam, J. H. Lee, P. N. Sisco, D. T. Co, M. Zhang,
M. R. Wasielewski, T. W. Odom, ACS Nano 2012, 6, 3318.
SUPPORTING INFORMATION
Additional supporting information may be found online in
the Supporting Information section at the end of the article.
Figure S1. EDX of the UCNP prepared which establishes
the molar ratio of the elements Na/Y/Yb/Er/F as
1/0.778/0.210/0.027/4.04.
Figure S2. Optical transmission microscopy of endothelial
cells (A) Before UCNP addition (B) After addition of
300 μg/mL UCNPs and incubation for 24 hours.
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